ROCHE INVIRASE CLEARS FDA IN 97 DAYS AS FIRST APPROVED PROTEASE INHIBITOR: NEW FORMULATION IN STUDY; INTERNATIONAL CONFIMATORY TRIAL SIZE, POWER INCREASED